4.3 Article

TIMP-1 and CD82, a promising combined evaluation marker for PDAC

Journal

ONCOTARGET
Volume 8, Issue 4, Pages 6496-6512

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.14133

Keywords

TIMP-1; CD82; interaction; cell motility; PDAC

Funding

  1. National Natural Science Foundation of China [30971403]
  2. National Basic Research Program of China (973 program) [2011CB504003]
  3. National Natural Science Youth Foundation of China [81501817]

Ask authors/readers for more resources

Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a widely secreted protein that regulates cell motility, proliferation, and apoptosis. Although it is recognized that TIMP-1-tetraspanin CD63 regulates epithelial cell apoptosis and proliferation, how TIMP-1 controls cell motility is not well understood. In this study, we identify tetraspanin CD82 (also called KAI1) as a component of the promiscuous TIMP-1 interacting protein complex on cell surface of human pancreatic adenocarcinoma cells. CD82 directly binds to TIMP-1 N-terminal region through its large extracellular loop and co-localizes with TIMP-1 in both cancer cell lines and clinical samples. Moreover, CD82 facilitates membrane-bound TIMP-1 endocytosis, which significantly contributes to the anti-migration effect of TIMP-1. CD82 silencing partially eliminates these functions. TIMP-1 and CD82 expression status in patients with pancreatic ductal adenocarcinoma (PDAC) might demonstrate future usefulness as a differentiation marker and give us new insight into tumorigenic metastatic potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available